Infigen, Inc.
DeForest, WI, US· latest recorded location
Infigen, Inc. is named on 9 US grants and 2 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 9
- Published applications
- 2
- Inventors
- 13
- Granted in 2026 so far
- 0
- Most recent grant
- 2 Mar 2004
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 2 | 0 |
By publication year.
Technology areas
Share of 11 documents
Recent patents
- Method of cloning porcine animals2 Mar 2004US 6,700,037 B2
- In vitro activation of mammalian oocytes20 Jan 2004US 6,680,199 B1
- Method of cloning animals5 Aug 2003US 6,603,059 B1
- Method of producing a polypeptide in an ungulate28 May 2002US 6,395,958 B1
- Method of cloning porcine animals10 Jul 2001US 6,258,998 B1
Most cited
By later US patents
- Method of cloning porcine animals51US 6,258,998 B12001
- Method of cloning bovines using reprogrammed non-embryonic bovine cells50US 6,011,197 A2000
- Parthenogenic oocyte activation42US 6,077,710 A2000
- Culture of totipotent embryonic inner cells mass cells and production of bovine animals24US 6,107,543 A2000
- Parthenogenic oocyte activation18US 6,194,202 B12001